TXG position history
The shares of 10X Genomics (TXG) that Duquesne Family Office LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q3: 116,715 shares, $3.3M, 0.19% of portfolio, New
- 2022 Q4: not held, Exit
- 2023 Q1: not held
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: not held
- 2026 Q2: 403,100 shares, $15M, 0.30% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|